Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nilutamide pneumonitis: a report on eight patients.
Pfitzenmeyer P, Foucher P, Piard F, Coudert B, Braud ML, Gabez P, Lacroix S, Mabille JP, Camus P. Pfitzenmeyer P, et al. Among authors: foucher p. Thorax. 1992 Aug;47(8):622-7. doi: 10.1136/thx.47.8.622. Thorax. 1992. PMID: 1412120 Free PMC article.
[Nitrosourea-induced lung diseases].
Massin F, Coudert B, Foucher P, Lombard JN, Reybet-Degat O, Jeannin L, Camus P. Massin F, et al. Among authors: foucher p. Rev Mal Respir. 1992;9(6):575-82. Rev Mal Respir. 1992. PMID: 1470749 Review. French.
[Respiratory manifestations of hemorrhagic rectocolitis].
Camus P, Piard F, Fur A, Gonzalez G, Coudert B, Foucher P, Jeannin L. Camus P, et al. Among authors: foucher p. Rev Mal Respir. 1991;8(5):421-31. Rev Mal Respir. 1991. PMID: 1767114 Review. French.
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Cadranel J, Mauguen A, Faller M, Zalcman G, Buisine MP, Westeel V, Longchampt E, Wislez M, Coudert B, Daniel C, Chetaille B, Michiels S, Blons H, Solassol J, De Fraipont F, Foucher P, Urban T, Lacroix L, Poulot V, Quoix E, Antoine M, Danton G, Morin F, Chouaid C, Pignon JP. Cadranel J, et al. Among authors: foucher p. J Thorac Oncol. 2012 Oct;7(10):1490-502. doi: 10.1097/JTO.0b013e318265b2b5. J Thorac Oncol. 2012. PMID: 22982650 Free article.
Antibiotic Use Does Not Appear to Influence Response to Nivolumab.
Kaderbhai C, Richard C, Fumet JD, Aarnink A, Foucher P, Coudert B, Favier L, Lagrange A, Limagne E, Boidot R, Ghiringhelli F. Kaderbhai C, et al. Among authors: foucher p. Anticancer Res. 2017 Jun;37(6):3195-3200. doi: 10.21873/anticanres.11680. Anticancer Res. 2017. PMID: 28551664
Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.
Kaderbhai CG, Richard C, Fumet JD, Aarnink A, Ortiz-Cuaran S, Pérol M, Foucher P, Coudert B, Favier L, Lagrange A, Limagne E, Boidot R, Ladoire S, Poudenx M, Ilie M, Hofman P, Saintigny P, Ghiringhelli F. Kaderbhai CG, et al. Among authors: foucher p. Oncoimmunology. 2017 Jun 16;6(9):e1339856. doi: 10.1080/2162402X.2017.1339856. eCollection 2017. Oncoimmunology. 2017. PMID: 28932641 Free PMC article.
65 results